FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/12/2023
Back to search
Official data from USPTO
HER2DX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
04/12/2023
Trademark type
Word
Nice classes
1, 5
Filing date
03/19/2021
Registration date
11/29/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/29/2022
Last transaction
11/29/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
ES
Examiner
HAN, DAWN L
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
R. S. (pessoa física)
Representatives
Donna A. Tobin Royer Cooper Cohen Braunfeld LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparations for scientific use; reagents for research purposes; reagents for medical research purposes; diagnostic reagents for scientific use or for research use; reagents for scientific use or for research use in the field of cancer; diagnostic reagents for clinical or medical laboratory use in the field of in vitro in biochemistryclinical chemistry and microbiology
Class 5
Products for medical diagnosticsmedical diagnostic reagentsmedical diagnostic assays for testing body fluids and tissuespecimen collection kits comprised of swabs for medical purposes and plastic bags for transmitting medical specimensall for use in cancer detection; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; medical reagents for clinical use; medical diagnostic reagents for the analysis of body fluids and tissue; diagnostic reagents for use in diagnostic testing for medical purposes; diagnostic biomarker reagents for cancer diagnosisprognosis and treatment for medical purposes; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of body fluids and tissuediagnostic reagents for medical useall for cancer diagnosisprognosis and treatment; pharmaceutical products for the treatment of cancer; biological preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical preparations for the treatment of cancer for oncological use; biological reagentsclinical medical reagents; diagnostic reagent kits consisting primarily of diagnostic reagents for medical usein the field of cancer
Publications
History of USPTO decisions and trademark events.
42 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/17/2023
FIMP
FINAL DISPOSITION PROCESSED
03/17/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/28/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/29/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/29/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/27/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/09/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/09/2022
GPNX
NOTIFICATION PROCESSED BY IB
10/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/13/2022
PUBO
PUBLISHED FOR OPPOSITION
09/13/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/07/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/24/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/04/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/15/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/15/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/15/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/15/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/14/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/14/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/14/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/14/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/03/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/26/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/26/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/26/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/26/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/26/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/26/2022
RFNT
REFUSAL PROCESSED BY IB
12/26/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/03/2021
RFRR
REFUSAL PROCESSED BY MPU
12/03/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/03/2021
CNRT
NON-FINAL ACTION WRITTEN
11/02/2021
DOCK
ASSIGNED TO EXAMINER
10/24/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/03/2021
Continuous trademark protection
Get notified about every new filing that threatens HER2DX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.